NCT03966898 2021-06-02A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast CancerJiangsu HengRui Medicine Co., Ltd.Phase 3 Unknown426 enrolled